Patents
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
07/2013
07/31/2013CN101460462B Spirocyclic nitriles as protease inhibitors
07/30/2013CA2479764C Hemiasterlin derivatives and uses thereof
07/25/2013US20130190488 Apoptosis promoters
07/25/2013US20130190327 Bis-fatty acid conjugates and their uses
07/25/2013US20130190296 Compositions and methods for the treatment of disease associated with trp-p8 expression
07/25/2013US20130190288 Benzyl sulfonamide derivatives as rorc modulators
07/24/2013EP2617812A1 Composition for maintaining platelet function
07/24/2013CN103214467A 5-[[4-[(2, 3-dimethyl-2H-indazole-6-yl) methylamino]-2-pyrimidyl] amino]-2-methyl-benzsulfamide derivative and preparation method and applications thereof
07/24/2013CN103214434A Improved method of 1-diphenylmethyl-4-(2-hydroxyethyl) piperazine synthesis technology
07/24/2013CN103214433A Raw liquid ammonia for producing morpholine
07/24/2013CN103214376A Substituted 4-aminocyclohexane derivatives
07/24/2013CN103212420A Morpholine synthetic catalyst and preparation method thereof
07/24/2013CN103212339A Hyamine fluorocarbon surfactant as well as preparation method and application thereof
07/24/2013CN101792422B Novel organic electroluminescent compounds and organic electroluminescent device using the same
07/24/2013CN101531599B Green electroluminescent compounds and organic electroluminescent device using the same
07/24/2013CN101405264B Piperidinyl urea derivatives as inhibitors of soluble epoxide hydrolase for the treatment of hypertension, inflammations and other diseases
07/24/2013CN101326171B Novel dual peptidase inhibitors as prodrugs for the therapy of inflammatory and other disorders
07/23/2013US8492385 Crystalline modifications of N-alpha-(2,4,6-triisopropylphenylsulfonyl)-3-hydroxyamidino- (L)- phenylalanine 4-ethoxycarbonylpiperazide and/or salts thereof
07/23/2013US8492375 1-benzoyl substituted diazepine derivatives as selective histamine H3 receptor agonists
07/23/2013US8492365 7-substituted tetracycline compounds
07/23/2013CA2681850C Styrenyl derivative compounds for treating ophthalmic diseases and disorders
07/23/2013CA2575033C Novel biaromatic compounds that activate ppar type receptors, and use thereof in cosmetic or pharmaceutical compositions
07/23/2013CA2566011C Method for producing quaternary ammonium compounds
07/23/2013CA2534675C Piperazine with or-substituted phenyl group and their use as glyt1 inhibitors
07/18/2013WO2013105053A1 Compounds having antibacterial activity, process for their preparation and pharmaceutical compositions comprising them
07/18/2013US20130184278 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
07/18/2013US20130184258 Compositions Useful as Inhibitors of Voltage-Gated Sodium Channels
07/18/2013US20130184238 Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy
07/17/2013CN103209969A Functionalised antifouling compounds and use thereof
07/17/2013CN103204960A Novel tertiary-amine oxime ester photoinitiator and preparation method thereof
07/17/2013CN103204828A Preparation method of 1-cyclohexyl-1-phenyl-3-piperidinepropanol hydrochloride
07/17/2013CN103204787A Mulin acetate comprising substituted squaric acid, and application thereof
07/17/2013CN103204781A 2, 7-bi-substituted fluorenone derivative and preparation method and application thereof
07/17/2013CN101835750B Cyclopropyl amide derivatives '978
07/17/2013CN101528695B Piperidine or piperazine substituted tetrahydro-naphthalene-1-carboxylic acid mtp inhibiting compounds
07/16/2013US8487135 Catalyst and process for preparing an amine
07/16/2013US8486311 Eyewear including catechol functionalized boron pyrromethene dye for neutralizing laser threat
07/16/2013CA2705474C O2-glycosylated 1-substituted diazen-1-ium-1,2-diolates
07/16/2013CA2485592C Anti tubercular drug: compositions and methods
07/11/2013WO2013102573A1 Process for the manufacture of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]-piperazine
07/11/2013US20130178457 Cannabinoid receptor modulators
07/11/2013US20130177900 Composition for maintaining function of platelets
07/10/2013EP2611772A1 2 - (benzyloxy) benzamides as lrrk2 kinase inhibitors
07/10/2013CN103201272A Process for preparing 1,4-bishydroxyethylpiperazine
07/10/2013CN103201267A Ampk-activating heterocyclic compounds and methods for using the same
07/10/2013CN103201260A Drug derivatives
07/10/2013CN102276556B Preparation method of 4-benzyl piperazi ethyliminumacyl (formimidoyl benzol) hydrazine compounds
07/10/2013CN101903095B Method for producing an amine
07/10/2013CN101863860B Synthesis method of 2-fluorine-4-substituted aminoaniline
07/09/2013US8481597 Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
07/09/2013US8481535 Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-HT2A serotonin receptor
07/09/2013CA2408408C Modulators of tnf- alpha signaling
07/04/2013WO2013102097A2 Cyclic amine compounds, compositions, and polyurethane foams made therefrom
07/04/2013WO2013102053A1 Amine polyether polyols and polyurethane foam compositions made from cyclic amine compounds
07/04/2013WO2013101954A1 3-phenyl-5-ureidoisothiazole-4-carboximide and 3-amino-5-phenylisothiazole derivatives as kinase inhibitors
07/04/2013WO2013101345A1 Formation of higher molecular weight cyclic polyamine compounds from cyclic polyamine compounds
07/04/2013WO2013100158A1 Actinic ray-sensitive or radiation-sensitive resin composition, and, actinic ray-sensitive or radiation-sensitive film and pattern forming method, each using the same
07/04/2013WO2013097773A1 Novel arylalkene derivatives and use thereof as selective estrogen receptor modulators
07/04/2013US20130172560 Processes for making cyclopropyl amide derivatives and intermediates associated therewith
07/04/2013US20130172363 Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics
07/04/2013US20130172355 Sulfur-containing compound, method of preparation and pharmaceutical uses thereof
07/03/2013EP2609079A1 Process for the manufacture of tmhq
07/03/2013EP2608791A1 A process for the preparation of imatinib base
07/03/2013EP2608666A1 Phenylamidines having a high fungicidal activity and use thereof
07/03/2013CN103189365A Method for producing a cyclic tertiary amine
07/03/2013CN103183630A Substituted 4-aminocyclohexane derivatives
07/03/2013CN103183625A Anti-HIV compound and preparation method and application thereof
07/03/2013CN101987824B Preparation method of high-purity conductive salt for super capacitor
07/02/2013US8476475 Premixture for preparing an absorbent for removing acidic gases from fluid streams
07/02/2013US8476336 Ophthalmologic composition and ophthalmologic lens
07/02/2013US8476279 Phenyl-piperazine derivatives as serotonin reuptake inhibitors
07/02/2013CA2545112C Novel ligands that are activators of the rar receptors, use in human medicine and in cosmetics
06/2013
06/27/2013WO2013095810A1 Reductive amination of diethanolamine and resulting product mixture
06/27/2013WO2013092850A1 Process for manufacturing aryloxyacetamides
06/26/2013CN103180297A Methods of facilitating neural cell survival using gdnf family ligand (gfl) mimetics or ret signaling pathway activators
06/26/2013CN103180287A A method to prepare beta-functionalized aliphatic esters
06/26/2013CN103172635A Piperazine or piperidine compound as well as salts, intermediates, preparation method and application thereof
06/26/2013CN103172593A Preparation technology of cinnarizine
06/26/2013CN103172512A Cajanin compound with similar structures, as well as preparation method and application thereof
06/26/2013CN102060808B Cinepazide acid addition salt and preparation method thereof
06/25/2013US8470831 Acrylamido derivatives useful as inhibitors of the mitochondrial permeability transition
06/25/2013CA2725425C Homocysteine synthase inhibitor
06/20/2013WO2013087934A1 Cationic para-phenylenediamines, composition comprising at least such compounds, implementation process therefor and use thereof
06/20/2013US20130158022 Acrylamide Compounds And Use Thereof For Inhibiting Apoptosis
06/20/2013US20130157851 Phenylamidines having a high fungicidal activity and use thereof
06/19/2013EP2603487A1 Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
06/19/2013CN103168028A Cyclic amide derivative
06/19/2013CN103168027A Processes for making cyclopropyl amide derivatives and intermediates associated therewith
06/19/2013CN103159702A Synthesis of 1-substituent-5-isopropyl-3, 8-dimethyl azulenyl sulfonyl piperazine and anti-gastric ulcer activity research
06/19/2013CN103159701A Method for synthesizing functionalized ionic liquid containing ester groups
06/19/2013CN103159700A Piperazine citrate preparation process
06/19/2013CN103159652A Preparation and application of sulfonamide compound
06/19/2013CN103159632A Ionic liquid compound with anion containing double Lewis base functional groups, preparation method thereof and application thereof
06/19/2013CN101973829B Trifluoromethylation of trifluoromethyl aryl sulfonium salt to heterocyclic compound under metal trigger
06/19/2013CN101914036B Method for preparing azobenzene derivatives
06/19/2013CN101137632B Process for making trans-1-((1r,3s)-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine
06/18/2013CA2443317C Materials, methods, and uses for photochemical generation of acids and/or radical species
06/13/2013WO2013002592A3 Method for purifying high-purity betulonic acid, method for preparing piperazine betulonic acid amide derivative using high-purity betulonic acid and derivative thereof, and method for purifying high-purity boc-lysinated betulonic acid using high-purity betulonic acid
06/13/2013CA2858752A1 1-substituted 4-arylpiperazines as kappa opioid receptor antagonists
06/12/2013EP2602244A1 (Meth) Acrylic acid ester, activation energy ray curing composition, and inkjet recording ink
1 ... 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 ... 341